Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Ltd share price and stock overview

Kwality Pharmaceuticals Ltd (NSE: KPL, BSE: 539997) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE552U01010 and a face value of Rs 10. As of 12 August 2026, it trades at Rs (3,310.50) with a market capitalisation of Rs 3248.63 crore. Figures are live and subject to change.

Kwality Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
3,310.50 176.40 (5.63%) upARrowC
As on: 12-Aug-2026 , 12:46 AM
Market Cap(₹Cr) 3248.63
Book Value(₹Cr) 320.5183613
BSE Code : 539997 NSE Symbol : KPL EPS(TTM) : 65.5 ISIN Demat : INE552U01010 P/E(TTM) : 47.8 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

10 Aug 26
Kwality Pharmaceuticals Ltd consolidated sales up 3.34% on year in Q2FY2026
Kwality Pharmaceuticals Ltd share price softened by 1.64% to Rs 2609.05. The Company's net profit inched up 1.
08 Aug 26
Kwality Pharmaceuticals re-appoints Aditya Arora as Whole Time Director for five years
Kwality Pharmaceuticals Limited announced that its board approved the re-appointment of Aditya Arora as a Whole Time Director for a further five-year period, commencing September 30, 2026, and subject to shareholder approval at the company’s 43rd Annual General Meeting.
24 Jul 26
Kwality Pharmaceuticals receives CDSCO approval to manufacture Pembroluzimab for preclinical studies
Kwality Pharmaceuticals has achieved a significant milestone in its biologics development journey after receiving permission from the Central Drugs Standard Control Organization (CDSCO) to manufacture pilot batches of Pembroluzimab for preclinical studies.
19 May 26
Kwality Pharma surges on strong Q4 numbers; PAT jumps 75%
The company's consolidated net profit surged 74.60% to Rs 25.30 crore in Q4 FY26, compared with Rs 14.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 3264.00 3450.00 3031.20 3310.50 568350 65502 1859190351.90 24471.70
10-08-26 2645.00 3134.10 2551.90 3134.10 409430 28037 1234729160.10 24583.80
07-08-26 2664.90 2709.00 2490.40 2611.80 62669 7418 164820164.60 24570.65
06-08-26 2550.00 2690.00 2550.00 2652.10 30735 4297 81361783.80 24636.00
05-08-26 2624.90 2624.90 2551.20 2559.10 9783 2005 25158125.50 24624.65
04-08-26 2525.00 2598.00 2512.50 2587.00 11878 2088 30417292.70 24614.90
03-08-26 2598.90 2625.00 2550.00 2562.00 12762 2362 32889289.10 24774.30
31-07-26 2500.00 2611.00 2500.00 2578.90 16797 2897 43116119.50 24383.60
30-07-26 2630.00 2630.00 2524.00 2545.60 11377 2069 29061573.30 24317.15
29-07-26 2610.00 2637.80 2535.60 2604.00 23878 4526 61588948.00 24250.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

3248.63

PE Ratio

47.8

PB Ratio

9.77

Dividend Yield

0

ROE

16.27

ROCE

18.29

Book Value (₹)

320.5183613

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 1580658 15.23 1580658 6
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4112211 39.63 4112211 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5692869 54.86 5692869 8
Total ShareHolding for Promoter & Group 5692869 54.86 5692869 8
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 324627 3.13 324627 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 188 0.00 188 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 58190 0.56 58190 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 383005 3.69 383005 10
plus  Non Institution
Bodies Corporate 138980 1.34 138980 93
Clearing Members 2750 0.03 2750 6
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 773972 7.46 773972 355
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 64784 0.62 64784 312
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1628697 15.70 1587301 11
Individuals holding nominal share capital up to Rs. 1 lakh 1590601 15.33 1590601 12483
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100540 0.97 100540 1
Sub Total 4300324 41.44 4258928 13261
Total Public Shareholding 4683329 45.14 4641933 13271
Total of Promoter & Public ShareHolding 10376198 100.00 10334802 13279
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 10376198 100.00 10334802 13279

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Net Sales370.20307.17251.03456.19262.01
OPM (%)14.6212.4416.7735.428.12
OP54.1438.2042.10161.5721.27
Other Income1.921.832.943.511.59
PBIDT82.3161.0446.55175.1730.44
INTEREST9.8810.396.022.922.67
PBDT72.4350.6640.53172.2627.76
PBT54.1424.009.04161.5721.27
EO0.00-7.10-16.530.000.00
PBT after EO54.1431.1025.57161.5721.27
TAXES14.347.486.2941.636.38
PAT39.8523.8019.37119.9915.15
EPS38.3622.7618.16115.1214.60
Raw Material44.6850.0745.1043.6963.08
Power and Fuel6.315.615.172.432.33
Employee Cost11.8310.6011.934.426.07
Other Manufacturing Expenses0.701.532.051.010.84
Selling and Administration Expenses9.409.3812.2910.3915.54
Miscellaneous Expenses0.560.760.700.140.41
Revenue (Growth %) 20.5222.36-44.9774.1188.10
PBIDT (Growth %)34.8331.13-73.43475.5570.51
PAT (Growth %) 67.4422.84-83.86692.2482.11
PBIDT (Margin %)22.2319.8718.5438.4011.62
PAT (Margin %) 10.767.757.7226.305.78

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 10.3810.3810.3810.3810.3810.38
Reserves Total 255.47215.57191.65172.1852.1336.72
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds265.85225.95202.03182.5662.5147.10
Secured Loans 112.4598.1290.1553.3132.7229.42
Unsecured Loans 0.000.000.120.708.515.55
Total Debt112.4598.1290.2754.0141.2334.97
Other Liabilities0.250.220.900.759.869.80
Total Liabilities378.55324.29293.20237.32113.6091.87
APPLICATION OF FUNDS :
Gross Block 229.75205.21168.72126.7080.7961.18
Less : Accumulated Depreciation 85.2967.0349.1535.9325.2719.55
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 144.46138.18119.5790.7755.5241.63
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.000.0014.2912.152.890.00
Producing Properties0.000.000.000.000.000.00
Investments 3.553.553.553.558.727.54
Current Assets, Loans & Advances
Inventories 83.4778.3993.3753.3617.3622.42
Sundry Debtors 155.90115.9873.2970.7137.7830.35
Cash and Bank Balance14.295.046.0910.875.131.15
Loans and Advances 31.2643.9741.8392.3741.1731.28
Total Current Assets284.91243.37214.57227.32101.4485.19
Less : Current Liabilities and Provisions
Current Liabilities 66.0866.6956.4964.0849.3939.82
Provisions 6.106.6013.5341.005.803.00
Total Current Liabilities & Provisions72.1873.2970.03105.0855.1942.82
Net Current Assets212.73170.08144.54122.2346.2542.37
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets1.610.030.000.040.200.32
Deferred Tax Liability0.000.000.410.310.160.12
Net Deferred Tax1.610.03-0.41-0.270.040.20
Other Assets16.1912.4411.648.890.170.12
Total Assets378.55324.28293.19237.32113.5991.86
Contingent Liabilities36.980.350.510.050.591.27

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities 0.835.660.99-17.40-14.44
Investing Activities -23.20-62.98-48.44-26.40-28.13
Net Cash Flow 3.991.93-5.26-0.4510.20
Operating Activities 26.3659.2442.1943.3552.77

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Functional Directors
RA
Ramesh Arora
Executive Director & MD
Exec.
AA
Ajay Arora
E D & Wholetime Director
Dir.
AA
Aditya Arora
Executive Director / Whole Time Director / CFO
Exec.
GA
Geeta Arora
E D & Wholetime Director
Dir.
AA
Anju Arora
E D & Wholetime Director
Dir.
Independent Directors
KK
Kartik Kapur
Independent Non Exe. Director
Ind.
PV
Prashanth Vellanki
Independent Non Exe. Director
Ind.
VKS
Vinod Kumar Sharma
Independent Non Exe. Director
Ind.
BM
Bhavesh Mahajan
Independent Non Exe. Director
Ind.
PMS
Preet Mohinder S Bedi
Independent Non Exe. Director
Ind.
Other Officials
GK
Gurpreet Kaur
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Kwality Pharmaceuticals Ltd? −

Kwality Pharmaceuticals Ltd trades on NSE under KPL and on BSE under code 539997. The ISIN is INE552U01010 and the face value is Rs 10.

What is the share price of Kwality Pharmaceuticals Ltd today? +

As of 12 August 2026, Kwality Pharmaceuticals Ltd trades at Rs 3,310.50, a change of 176.40 (5.63%) on the day. Prices are live and subject to change.

What is the market capitalisation of Kwality Pharmaceuticals Ltd? +

As of 12 August 2026, Kwality Pharmaceuticals Ltd has a market cap of about Rs 3248.63 crore. This figure is live and moves with the share price.

Is Kwality Pharmaceuticals Ltd profitable? +

In March 2025, Kwality Pharmaceuticals Ltd reported a profit after tax of Rs 39.85 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Kwality Pharmaceuticals Ltd? +

: As of 12 August 2026, the PE (TTM) for Kwality Pharmaceuticals Ltd is 47.8 and the price-to-book ratio is 9.77. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Kwality Pharmaceuticals Ltd pay a dividend? +

As of 12 August 2026, the dividend yield for Kwality Pharmaceuticals Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Kwality Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 54.86% of Kwality Pharmaceuticals Ltd. Public shareholding is 45.14%, including mutual funds at 0.00% and foreign institutional investors at 3.13%.

What were the latest annual financials of Kwality Pharmaceuticals Ltd? +

In March 2025, Kwality Pharmaceuticals Ltd reported net sales of Rs 370.20 crore, revenue growth of 20.52%, and earnings per share of Rs 38.36.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web